ArticleFrontiers in oncology2019

A Multicenter Phase II Trial of Docetaxel, Cisplatin, and Cetuximab (TPEx) Followed by Cetuximab and Concurrent Radiotherapy for Patients With Local Advanced Squamous Cell Carcinoma of the Head and Neck (CSPOR HN01: ECRIPS Study).

Sadamoto Zenda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.